
### [MONDO:0015564](http://purl.obolibrary.org/obo/MONDO_0015564)
**Label:** Castleman disease

**Subclasses:** [MONDO:0007845](http://purl.obolibrary.org/obo/MONDO_0007845) (Kaposi sarcoma, susceptibility to), [MONDO:0019753](http://purl.obolibrary.org/obo/MONDO_0019753) (localized Castleman disease), [MONDO:0019754](http://purl.obolibrary.org/obo/MONDO_0019754) (multicentric Castleman disease), [MONDO:0019752](http://purl.obolibrary.org/obo/MONDO_0019752) (pediatric Castleman disease), 

**Corr. equiv. classes:** [OMIM:148000](http://purl.obolibrary.org/obo/OMIM_148000), [Orphanet:93682](http://www.orpha.net/ORDO/Orphanet_93682), [Orphanet:93686](http://www.orpha.net/ORDO/Orphanet_93686), [Orphanet:93685](http://www.orpha.net/ORDO/Orphanet_93685), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 62.50%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) 62.50%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 62.50%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) 62.50%
- [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 41.37%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 41.37%
- [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 32.91%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) 32.91%
- [HP:0000953](http://purl.obolibrary.org/obo/HP_0000953) (Hyperpigmentation of the skin) 15.83%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) 14.97%
- [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 14.80%
- [HP:0001000](http://purl.obolibrary.org/obo/HP_0001000) (Abnormality of skin pigmentation) 14.71%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 14.11%
- [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 14.11%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 13.52%


